{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:36:40Z","timestamp":1792658200852,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012304","name":"Johns Hopkins University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejpb.2021.12.011","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T03:14:23Z","timestamp":1640747663000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model"],"prefix":"10.1016","volume":"170","author":[{"given":"Riccardo","family":"Serra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Mangraviti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah L.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tovi","family":"Shapira-Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwan","family":"Alomari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arba","family":"Cecia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Darjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Brem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakir","family":"Rottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Domb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Tyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.ejpb.2021.12.011_b0005","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-oncology."},{"issue":"7","key":"10.1016\/j.ejpb.2021.12.011_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.ejpb.2021.12.011_b0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2021.12.011_b0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","article-title":"Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas","volume":"74","author":"Brem","year":"1991","journal-title":"J. Neurosurg."},{"issue":"8956","key":"10.1016\/j.ejpb.2021.12.011_b0025","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","article-title":"Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas","volume":"345","author":"Brem","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejpb.2021.12.011_b0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","article-title":"Mechanisms of glioma-associated neovascularization","volume":"181","author":"Hardee","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.ejpb.2021.12.011_b0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","article-title":"Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1\u2013ZEB1 axis","volume":"359","author":"Joseph","year":"2015","journal-title":"Cancer Lett."},{"issue":"6560","key":"10.1016\/j.ejpb.2021.12.011_b0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejpb.2021.12.011_b0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/S1152851704001115","article-title":"Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis","volume":"7","author":"Kaur","year":"2005","journal-title":"Neuro-oncology."},{"issue":"1","key":"10.1016\/j.ejpb.2021.12.011_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14990-w","article-title":"HIF-1\u03b1-targeting acriflavine provides long term survival and radiological tumor response in brain cancer therapy","volume":"7","author":"Mangraviti","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejpb.2021.12.011_b0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1023\/A:1011995728760","article-title":"Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors","volume":"16","author":"Domb","year":"1999","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2021.12.011_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal","year":"2003","journal-title":"Neuro-oncology."},{"issue":"3","key":"10.1016\/j.ejpb.2021.12.011_b0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00701-005-0707-z","article-title":"Gliadel\u00ae wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial","volume":"148","author":"Westphal","year":"2006","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.ejpb.2021.12.011_b0070","series-title":"Drug-Impregnated Polymer Delivery","first-page":"275","author":"Serra","year":"2019"},{"issue":"6","key":"10.1016\/j.ejpb.2021.12.011_b0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrd1414","article-title":"Targeted therapy for brain tumours","volume":"3","author":"Lesniak","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejpb.2021.12.011_b0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2018.12.048","article-title":"Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer","volume":"295","author":"Shapira-Furman","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2021.12.011_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2016.06.018","article-title":"Polylactic acid (PLA) controlled delivery carriers for biomedical applications","volume":"107","author":"Tyler","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ejpb.2021.12.011_b0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F","article-title":"In vitro degradation of thin poly (DL-lactic-co-glycolic acid) films","volume":"46","author":"Lu","year":"1999","journal-title":"J. Biomed. Mater. Res. Off. J. Soc. Biomater. Jpn. Soc. Biomater. Austral. Soc. Biomater."},{"issue":"4","key":"10.1016\/j.ejpb.2021.12.011_b0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","article-title":"Angiogenesis in gliomas: biology and molecular pathophysiology","volume":"15","author":"Fischer","year":"2005","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.ejpb.2021.12.011_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-9-133","article-title":"Knock down of HIF-1\u03b1 in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres","volume":"9","author":"M\u00e9ndez","year":"2010","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.ejpb.2021.12.011_b0105","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W","article-title":"Expression of hypoxia-inducible factor 1\u03b1 in brain tumors: association with angiogenesis, invasion, and progression","volume":"88","author":"Zagzag","year":"2000","journal-title":"Cancer: Interdiscip. Int. J. Am. Cancer Soc."},{"issue":"7","key":"10.1016\/j.ejpb.2021.12.011_b0110","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/cdd.2014.31","article-title":"Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy","volume":"21","author":"Auffinger","year":"2014","journal-title":"Cell Death Differ."},{"issue":"5867","key":"10.1016\/j.ejpb.2021.12.011_b0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(00)56423-X","article-title":"Acriflavine as a urinary antiseptic","volume":"227","author":"Assinder","year":"1936","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejpb.2021.12.011_b0120","first-page":"841","article-title":"Topical effect of acriflavine compounds on growth and spread of malignant cells","volume":"23","author":"Goldie","year":"1959","journal-title":"J. Natl Cancer Inst."},{"issue":"5","key":"10.1016\/j.ejpb.2021.12.011_b0125","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/carcin\/bgu004","article-title":"Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer","volume":"35","author":"Shay","year":"2014","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.ejpb.2021.12.011_b0130","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.18632\/oncotarget.6490","article-title":"Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy","volume":"7","author":"Weijer","year":"2016","journal-title":"Oncotarget."},{"issue":"7","key":"10.1016\/j.ejpb.2021.12.011_b0135","first-page":"3549","article-title":"Antitumor activity of acriflavine in human hepatocellular carcinoma cells","volume":"34","author":"Lee","year":"2014","journal-title":"Anticancer Res."},{"issue":"12","key":"10.1016\/j.ejpb.2021.12.011_b0140","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/j.1349-7006.2011.02097.x","article-title":"Novel activity of acriflavine against colorectal cancer tumor cells","volume":"102","author":"Hassan","year":"2011","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2021.12.011_b0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tranon.2016.11.008","article-title":"Acriflavine inhibits acquired drug resistance by blocking the epithelial-to-mesenchymal transition and the unfolded protein response","volume":"10","author":"Dekervel","year":"2017","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.ejpb.2021.12.011_b0150","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3892\/ijo.2012.1555","article-title":"Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma","volume":"41","author":"Mayer","year":"2012","journal-title":"Int. J. Oncol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112100360X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112100360X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:46:32Z","timestamp":1760546792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112100360X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"alternative-id":["S093964112100360X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.12.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined intracranial Acriflavine, temozolomide and radiation extends survival in a rat glioma model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}